Nektar Therapeutics
NKTR
NKTR
242 hedge funds and large institutions have $3.18B invested in Nektar Therapeutics in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
242
Holders Change
-37
Holders Change %
-13.26%
% of All Funds
5.35%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
24
Increased
85
Reduced
83
Closed
57
Calls
$12.8M
Puts
$20.2M
Net Calls
-$7.44M
Net Calls Change
-$798K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$81.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$40.9M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$29.6M |
| 4 |
M&T Bank
Buffalo,
New York
|
+$18.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$9.5M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$29.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$19.1M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$16M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$13.4M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
-$9.7M |
